GENEVA, July 1 -- CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. filed a patent application (CN2025/141206) for “USE OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE OR COMBINATION-THERAPY DRUG THEREOF FOR TREATING NON-SMALL CELL LUNG CANCER”. With publication no. WO/2026/124488, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....